Efavirenz/Emtricitabin/Tenofovir Viatris

Efavirenz/Emtricitabin/Tenofovir Viatris is a medicine authorised by Swissmedic under authorisation number 67093. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 30 August 2019 and the authorisation is valid without a time limit. ATC code J05AR06 places the medicine in the group Antivirals for systemic use.

  • Dispensing category A
  • Authorisation number 67093
  • ATC J05AR06
  • Synthetic medicines
Authorisation data
Authorisation number67093
NameEfavirenz/Emtricitabin/Tenofovir Viatris
Full nameEfavirenz/Emtricitabin/Tenofovir Viatris, Filmtabletten
Authorisation holderViatris Pharma GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ05AR06
First authorisation30 August 2019
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Efavirenz/Emtricitabin/Tenofovir Viatris, FilmtablettenA30 August 2019

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
230Tablette(n)J05AR0608.03.0.A
330Tablette(n)J05AR0608.03.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Efavirenz/Emtricitabin/Tenofovir Viatris authorised in Switzerland?

Yes. Efavirenz/Emtricitabin/Tenofovir Viatris is authorised by Swissmedic under authorisation number 67093, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Efavirenz/Emtricitabin/Tenofovir Viatris have?

Efavirenz/Emtricitabin/Tenofovir Viatris is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Efavirenz/Emtricitabin/Tenofovir Viatris?

The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com